期刊文献+

奥曲肽对人类前列腺癌PC-3细胞凋亡及其对cyclinE蛋白表达的影响 被引量:1

Effects of sandostatin on apoptosis of human prostate cancer cell PC-3 and the expression of cyclin E
下载PDF
导出
摘要 目的:研究生长抑素类似物奥曲肽对人类前列腺癌PC-3细胞凋亡及其对cyclinE蛋白表达的影响。方法:用奥曲肽对体外培养的人类前列腺癌PC-3细胞进行药物处理,采用MTT比色分析法测定奥曲肽不同剂量组对前列腺癌PC-3细胞生长的调控作用;采用流式细胞术分析奥曲肽对PC-3细胞的周期分布的影响,免疫细胞化学方法观察奥曲肽对前列腺癌PC-3细胞周期调控蛋白cyclinE的影响。结果:奥曲肽可抑制前列腺癌PC-3细胞的增殖,诱导其凋亡,改变细胞周期分布,使G0/G1期细胞比例增高,S期比例降低,同时还可使cyclinE蛋白表达下降。上述作用具有剂量和时间依赖性。结论:奥曲肽可诱导前列腺癌PC-3细胞凋亡,改变细胞周期分布,影响细胞周期调控蛋白表达,从而抑制细胞增殖。 Objective: To investigate the effects of sandostatin on apoptosis of human prostate cancer cell PC-3 and the following expression of cyclin E of PC-3. Methods: Sandostatin was added into the culture medium of PC-3 cells. The cell growth regulation with different doses of sadostatin in PC-3 is evaluated by MTT; the cell cycle distribution of PC-3 treated with sadostatin is detected by FCM; the expression of cyclin E is examined by immunohistochcmistry. Results: Sadostatin could restrain the growth of PC-3 and induce the apoptosis, and also it could change the cell cycle distribution. Sadostatin increased the proportion of G0/G1, and descended the proportion of S phase. At the same time, it downregulated the expression of cyclin E. These effects were associated with time and dose. Conclusion: Sandostatin can induce apoptosis of PC-3, change the cell cycle distribution and downregulate the expression of cyclin E and then restrain cell proliferation.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第12期928-930,共3页 Journal of Nanjing Medical University(Natural Sciences)
关键词 奥曲肽 PC-3细胞系 MTT法 流式细胞术 CYCLIN E sandostatin PC-3 cell line MTT FCM cyclin E
  • 相关文献

参考文献7

  • 1Jenkins PJ, Emery M, Howling S J, et al. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR[J]. Horm Res, 2004,62(5):227-232.
  • 2Dimitroulopoulos D, Xinopoulos D, Tsamakidis K, et al.The role of sandostatin LAR in treating patients with advanced hepatocellular cancer[J]. Hepatogastroenterology,2002,49 (47), 1245-1250.
  • 3Joensuu TK, Nilsson S, Holmberg AR, et al. Phase Ⅰ trial on sms-D70 somatostatin analogue in advanced prostate and renal cell cancer [J]. Ann N Y Acad Sci,2004,1028:361-374.
  • 4Sinisi AA, Rossi V, Prezioso D, et al. The role of somatostatin analogs in the management of prostate cancer[J]. J Endocrinol Invest. 2003,26(8 Suppl):120-124.
  • 5Mosca A, Dogliotti L, Berruti A, et al. Somatostatin receptors: from basic science to clinical approach.Unlabeled somatostatin analogues-1: Prostate cancer [J].Dig Liver Dis, 2004,36 Suppl 1:S60-67.
  • 6Medina DL, Toro MJ, Santisteban P. Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and cyclin Excyclin-dependent kinase 2 complexes [J]. J Biol Chem, 2000,275 (20): 15549-15556.
  • 7Martinsson HS, Starborg M, Erlandsson F, et al. Single cell analysis of G1 check points-the relationship between the restriction point and phosphorylation of pRb [J]. Exp Cell Res, 2005,305(2):383-391.

同被引文献10

  • 1侯振江,李永乾.蛋白质组学及其在前列腺癌研究中的应用[J].中华男科学杂志,2006,12(4):358-361. 被引量:3
  • 2Kouroumalis E,Skordilis P,Thermos K,et al.Treatment of hepatocellular carcinoma with octreotide:a randomised controlled study[J].Gut,1998,42(3):442-447.
  • 3Filosso PL,Ruffini E,Oliaro A,et al.Long-term survival of atypical bronchial carcinoids with liver metastases,treated with octreotide[J].Eur J Cardiothorac Surg,2002,21(5):913-917.
  • 4Foley R,Hollywood D,Lawler M.Molecular pathology of prostate cancer:the key to identifying new biomarkers of disease[J].Endocr Relat Cancer,2004,11(3):477-488.
  • 5Abrahamsson PA.Neuroendocrine cells in tumour growth of the prostate[J].Endocr Relat Cancer,1999,6(4):503-519.
  • 6Morichetti D,Mazzucchelli R,Santinelli A,et al.Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation[J].Int J Immunopathol Pharmacol,2010,23(2):511-522.
  • 7Xing Z,Zhou Z,Yu R,et al.XAF1expression and regulatory effects of somatostatin on XAF1in prostate cancer cells[J].J Exp Clin Cancer Res,2010,29:162.
  • 8Vainas IG.Octreotide in the management of hormone-refractory prostate cancer[J].Chemotherapy,2001,47(Suppl 2):109-126.
  • 9Friedlander TW,Weinberg VK,Small EJ,et al.Effect of the somatostatin analog octreotide acetate on circulating insulinlike growth factor-1 and related peptides in patients with nonmetastatic castration-resistant prostate cancer:results of a phase Ⅱstudy[J].Urol Oncol,2012,30(4):408-414.
  • 10骆磊,张桂铭,孙立江,葛银林,马晓军,董大海,张鲁东.奥曲肽对前列腺癌细胞株PC-3的抑制作用及对VEGF表达的影响[J].临床泌尿外科杂志,2010,25(6):469-473. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部